WhitTier Trust Company’s Dr. Reddy's Laboratories RDY Stock Holding History

WhitTier Trust Company’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,375	Closed	-$12K	–	949
2016 Q4	$12K	Hold	1,375	–	–	﹤0.01%	749
2016 Q3	$13K	Hold	1,375	–	–	﹤0.01%	739
2016 Q2	$14K	Hold	1,375	–	–	﹤0.01%	732
2016 Q1	$12K	Hold	1,375	–	–	﹤0.01%	757
2015 Q4	$13K	Hold	1,375	–	–	﹤0.01%	738
2015 Q3	$18K	Hold	1,375	–	–	﹤0.01%	703
2015 Q2	$15K	Hold	1,375	–	–	﹤0.01%	751
2015 Q1	$16K	Hold	1,375	–	–	﹤0.01%	752
2014 Q4	$14K	Hold	1,375	–	–	﹤0.01%	758
2014 Q3	$14K	Hold	1,375	–	–	﹤0.01%	753
2014 Q2	$12K	Hold	1,375	–	–	﹤0.01%	778
2014 Q1	$12K	Hold	1,375	–	–	﹤0.01%	794
2013 Q4	$11K	Hold	1,375	–	–	﹤0.01%	764
2013 Q3	$10K	Hold	1,375	–	–	﹤0.01%	761
2013 Q2	$10K	Buy	+1,375	New	+$10K	﹤0.01%	750

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

WhitTier Trust Company's RDY Position: Q1 2017 in Review

WhitTier Trust Company sold out of Dr. Reddy's Laboratories (RDY) in Q1 2017, closing a stake of 1,375 shares — an estimated $12K sold.

WhitTier Trust Company first reported a position in RDY in Q2 2013 and held it in 15 quarters. The position peaked at $18K in Q3 2015. 134 funds tracked by Wall St. Rank hold RDY as of Q1 2017.

WhitTier Trust Company reported no remaining Dr. Reddy's Laboratories position as of Q1 2017 after selling out during the quarter.
WhitTier Trust Company sold 1,375 Dr. Reddy's Laboratories shares in Q1 2017, an estimated $12K.
WhitTier Trust Company first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 15 quarters.
WhitTier Trust Company's Dr. Reddy's Laboratories position peaked at $18K in Q3 2015.
134 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2017.

Based on WhitTier Trust Company's 13F filing for Q1 2017, filed 27 Apr 2017.